Year: 2007
Type: review
Abstract: Numerous failures in clinical stroke trials have led to some pessimism in the field. This short review examines the following questions: Can experimental models of stroke be validated? How can combination stroke therapies be productively pursued? Can we achieve neuroprotection without reperfusion? And finally, can we move from a pure neurobiology view of stroke towards a more integrative approach targeting all cell types within the entire neurovascular unit? Emerging data from both experimental models and clinical findings suggest that neurovascular mechanisms may provide new opportunities for treating stroke. Ultimately, both bench-to-bedside and bedside-back-to-bench interactions may be required to overcome the translational hurdles for this challenging disease.
Source: British Journal of Pharmacology
Author: E H Lo
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Remodeling and recovery in the neurovascular unit, Matrix metalloproteinase-9 mediated cell death in stroke, Mechanisms of Hemorrhage and Edema in tPA Stroke Therapy, CD47 as a neurovascular target for stroke therapy, Interdepartmental Stroke Program, tPA plus MMP inhibition for combination stroke therapy
OpenAlex ID: W1556471290
